美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

CITIUS ONCOLOGY INC

1.09

-0.0200-1.80%

成交量：5.98万

成交额：6.50万

市值：9,622.00万

市盈率：-3.56

高：1.11

开：1.11

低：1.08

收：1.11

52周最高：6.19

52周最低：0.5506

股本：8,827.52万

流通股本：1,232.10万

量比：0.51

换手率：0.48%

股息：- -

股息率：- -

每股收益(TTM):-0.3060

每股收益(LYR):-0.3380

净资产收益率：-47.41%

总资产收益率：-13.96%

市净率：1.65

市盈率(LYR):-3.23

数据加载中...

总览公司新闻资讯公告

Citius Oncology与Uniphar达成独家协议将淋巴瘤药物Lymphir™分销版图扩展至欧盟

Citius Oncology, Inc.盘中异动早盘股价大跌5.42%

Citius Oncology, Inc.盘中异动大幅拉升5.61%

Citius Oncology, Inc.盘中异动早盘急速下挫6.96%

Citius Oncology, Inc.盘中异动早盘大幅下挫5.31%报1.07美元

Citius Oncology完成1800万美元的同时注册直接发行和私募配售，价格符合纳斯达克规则

Citius Oncology Inc - 直接发行以每股1.09美元购买1,284,404股普通股

Citius Oncology 宣布以市场定价进行1800万美元的注册直销及私人投资

Citius Oncology通过与Er-Kim的独家协议扩展Lymphir™在土耳其和中东国家的分销

Citius Oncology 宣布 Lymphir™ 上市，作为切肤性 T 细胞淋巴瘤的新型癌症免疫疗法

Citius Oncology, Inc.盘中异动急速上涨5.62%

Citius Oncology与麦克森签署美国分销协议以支持Lymphir™商业推广

Citius Oncology与Eversana签订独家商业化协议，助力计划于2025年第四季度推出Lymphir™

Citius Oncology宣布完成900万美元注册直接发行和同步私募配售定价

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/CTOR/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTOR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTOR\",,,,,undefined,":{"symbol":"CTOR","market":"US","secType":"STK","nameCN":"CITIUS ONCOLOGY INC","latestPrice":1.09,"timestamp":1772139600000,"preClose":1.11,"halted":0,"volume":59750,"delay":0,"changeRate":-0.018018018018018032,"floatShares":12321000,"shares":88275200,"eps":-0.305988,"marketStatus":"盘前交易","change":-0.02,"latestTime":"02-27 08:52:06 EST","open":1.11,"high":1.11,"low":1.08,"amount":64982.170074999995,"amplitude":0.027027,"askPrice":1.14,"askSize":2654,"bidPrice":0.9877,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.305988,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772202600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":1.09,"postHourTrading":{"tag":"盘后","latestPrice":1.11,"preClose":1.09,"latestTime":"18:59 EST","volume":201,"amount":223.09,"timestamp":1772150383392,"change":0.02,"changeRate":0.018349,"amplitude":0.018349},"volumeRatio":0.5133284992668785},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTOR\",,,,,undefined,":{"symbol":"CTOR","floatShares":12321000,"roa":"-13.96%","roe":"-47.41%","lyrEps":-0.337956,"volumeRatio":0.5133284992668785,"shares":88275200,"dividePrice":0,"high":1.11,"amplitude":0.027027,"preClose":1.11,"low":1.08,"week52Low":0.5506,"pbRate":"1.65","psRate":"24.40","week52High":6.19,"institutionHeld":0,"latestPrice":1.09,"committee":-0.927378,"eps":-0.305988,"divideRate":0,"volume":59750,"delay":0,"ttmEps":-0.305988,"open":1.11,"prevYearClose":1,"prevWeekClose":1.16,"prevMonthClose":1.06,"prevQuarterClose":1,"fiveDayClose":1.21,"twentyDayClose":1.09,"sixtyDayClose":1.37},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTOR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-13","symbol":"CTOR","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1770958800000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2025-12-23","symbol":"CTOR","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1766466000000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2025-08-12","symbol":"CTOR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTOR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTOR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1759035600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTOR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTOR","date":"2026-02-26","current":-3.562231,"percent":0.486842,"low":-14.569058,"twenty":-5.66094,"median":-4.109523,"eighty":-3.425044,"high":-1.770477,"avg":-4.526251,"sd":1.875464,"marketCap":97985476},"quantilePoints":[{"date":"2024-08-23","current":-7.506449,"twenty":-8.175502,"median":-7.996,"eighty":-7.800179,"marketCap":131199450},{"date":"2024-08-30","current":-6.464428,"twenty":-8.028637,"median":-7.567643,"eighty":-6.639734,"marketCap":126208166},{"date":"2024-09-06","current":-6.847911,"twenty":-7.922567,"median":-7.149219,"eighty":-6.405992,"marketCap":133695091},{"date":"2024-09-13","current":-5.989639,"twenty":-7.726747,"median":-6.50095,"eighty":-6.274513,"marketCap":116938640},{"date":"2024-09-20","current":-6.099206,"twenty":-7.555404,"median":-6.464428,"eighty":-5.97503,"marketCap":119077761},{"date":"2024-09-27","current":-5.222673,"twenty":-7.472896,"median":-6.354861,"eighty":-5.953117,"marketCap":101964790},{"date":"2024-10-04","current":-4.309619,"twenty":-7.088957,"median":-6.190511,"eighty":-5.617113,"marketCap":84138777},{"date":"2024-10-11","current":-3.542653,"twenty":-6.749301,"median":-6.099206,"eighty":-5.018149,"marketCap":69164927},{"date":"2024-10-18","current":-3.944397,"twenty":-6.661648,"median":-5.953117,"eighty":-4.16353,"marketCap":77008372},{"date":"2024-10-25","current":-4.399098,"twenty":-6.559386,"median":-5.916595,"eighty":-4.331532,"marketCap":85885727},{"date":"2024-10-31","current":-4.419185,"twenty":-6.486341,"median":-5.66094,"eighty":-4.324228,"marketCap":86277899},{"date":"2024-11-08","current":-4.602892,"twenty":-6.464428,"median":-5.16789,"eighty":-4.287705,"marketCap":89864492},{"date":"2024-11-15","current":-3.904222,"twenty":-6.464428,"median":-4.930496,"eighty":-4.287705,"marketCap":76224028},{"date":"2024-11-22","current":-3.564201,"twenty":-6.420601,"median":-4.784407,"eighty":-3.944397,"marketCap":69585621},{"date":"2024-11-29","current":-3.356755,"twenty":-6.347557,"median":-4.693102,"eighty":-3.842134,"marketCap":65535551},{"date":"2024-12-06","current":-5.916595,"twenty":-6.296426,"median":-4.747885,"eighty":-3.776395,"marketCap":115512559},{"date":"2024-12-13","current":-3.907874,"twenty":-6.201468,"median":-4.620605,"eighty":-3.842134,"marketCap":76295332},{"date":"2024-12-20","current":-3.871352,"twenty":-6.164946,"median":-4.528752,"eighty":-3.842134,"marketCap":75582291},{"date":"2024-12-27","current":-3.50613,"twenty":-6.135728,"median":-4.435255,"eighty":-3.725263,"marketCap":68451887},{"date":"2025-01-03","current":-4.012144,"twenty":-6.10651,"median":-4.399098,"eighty":-3.717959,"marketCap":84851818},{"date":"2025-01-10","current":-3.992285,"twenty":-6.033466,"median":-4.399098,"eighty":-3.747177,"marketCap":84431834},{"date":"2025-01-17","current":-4.465946,"twenty":-5.967726,"median":-4.376046,"eighty":-3.723807,"marketCap":94449170},{"date":"2025-01-24","current":-4.296782,"twenty":-5.953117,"median":-4.35308,"eighty":-3.739872,"marketCap":90871550},{"date":"2025-01-31","current":-4.262949,"twenty":-5.953117,"median":-4.346141,"eighty":-3.761786,"marketCap":90156026},{"date":"2025-02-07","current":-4.026118,"twenty":-5.938508,"median":-4.309619,"eighty":-3.767526,"marketCap":85147358},{"date":"2025-02-14","current":-4.330615,"twenty":-5.916595,"median":-4.296782,"eighty":-3.799613,"marketCap":91587074},{"date":"2025-02-21","current":-3.72014,"twenty":-5.901986,"median":-4.296782,"eighty":-3.761786,"marketCap":85862882},{"date":"2025-02-28","current":-3.689139,"twenty":-5.807029,"median":-4.262949,"eighty":-3.720436,"marketCap":85147358},{"date":"2025-03-07","current":-3.162119,"twenty":-5.639027,"median":-4.229116,"eighty":-3.689139,"marketCap":72983450},{"date":"2025-03-14","current":-2.294087,"twenty":-5.507546,"median":-4.152992,"eighty":-3.653403,"marketCap":52948777},{"date":"2025-03-21","current":-1.891071,"twenty":-5.317631,"median":-4.127617,"eighty":-3.617985,"marketCap":43646965},{"date":"2025-03-28","current":-2.030577,"twenty":-5.251891,"median":-4.059951,"eighty":-3.565808,"marketCap":46866823},{"date":"2025-04-04","current":-2.191783,"twenty":-5.220193,"median":-4.053963,"eighty":-3.506186,"marketCap":50587548},{"date":"2025-04-11","current":-1.919282,"twenty":-5.198143,"median":-4.02178,"eighty":-3.38992,"marketCap":44298092},{"date":"2025-04-17","current":-2.002676,"twenty":-5.149629,"median":-4.014793,"eighty":-3.224122,"marketCap":46222851},{"date":"2025-04-25","current":-1.987175,"twenty":-5.113107,"median":-3.992285,"eighty":-3.104751,"marketCap":45865089},{"date":"2025-05-02","current":-2.759104,"twenty":-5.076585,"median":-3.944397,"eighty":-2.759104,"marketCap":63681637},{"date":"2025-05-09","current":-2.619599,"twenty":-4.930496,"median":-3.907874,"eighty":-2.693382,"marketCap":60461779},{"date":"2025-05-16","current":-2.437632,"twenty":-4.930496,"median":-3.890787,"eighty":-2.691522,"marketCap":63331031},{"date":"2025-05-23","current":-2.506208,"twenty":-4.784407,"median":-3.875146,"eighty":-2.619599,"marketCap":65112685},{"date":"2025-05-30","current":-2.451953,"twenty":-4.784407,"median":-3.871352,"eighty":-2.502848,"marketCap":63703103},{"date":"2025-06-06","current":-2.671453,"twenty":-4.755189,"median":-3.805483,"eighty":-2.487546,"marketCap":69405829},{"date":"2025-06-13","current":-4.04849,"twenty":-4.660231,"median":-3.776135,"eighty":-2.502848,"marketCap":105182030},{"date":"2025-06-20","current":-4.268817,"twenty":-4.617062,"median":-3.83483,"eighty":-2.506208,"marketCap":110906223},{"date":"2025-06-27","current":-9.639263,"twenty":-4.842843,"median":-3.873249,"eighty":-2.506208,"marketCap":250433407},{"date":"2025-07-03","current":-14.569058,"twenty":-5.098498,"median":-3.876214,"eighty":-2.511716,"marketCap":378512206},{"date":"2025-07-11","current":-8.950744,"twenty":-5.244587,"median":-3.890787,"eighty":-2.545647,"marketCap":232545306},{"date":"2025-07-18","current":-4.40652,"twenty":-5.303022,"median":-3.909331,"eighty":-2.598329,"marketCap":114483843},{"date":"2025-07-25","current":-5.370447,"twenty":-5.303022,"median":-3.944397,"eighty":-2.622079,"marketCap":139527183},{"date":"2025-08-01","current":-7.246465,"twenty":-5.617113,"median":-3.968341,"eighty":-2.631999,"marketCap":188267172},{"date":"2025-08-08","current":-6.066045,"twenty":-5.92757,"median":-3.993409,"eighty":-2.65122,"marketCap":157599217},{"date":"2025-08-15","current":-5.071831,"twenty":-5.92757,"median":-4.017441,"eighty":-2.668242,"marketCap":134797404},{"date":"2025-08-22","current":-4.806444,"twenty":-5.916595,"median":-4.026118,"eighty":-2.679481,"marketCap":127744051},{"date":"2025-08-29","current":-6.251327,"twenty":-5.92757,"median":-4.051227,"eighty":-2.692266,"marketCap":166145638},{"date":"2025-09-05","current":-5.514142,"twenty":-5.933303,"median":-4.056957,"eighty":-2.700326,"marketCap":146552992},{"date":"2025-09-12","current":-5.938837,"twenty":-5.933303,"median":-4.063335,"eighty":-2.734303,"marketCap":157840405},{"date":"2025-09-19","current":-5.498923,"twenty":-5.933303,"median":-4.134553,"eighty":-2.759104,"marketCap":146148523},{"date":"2025-09-26","current":-5.71888,"twenty":-5.924891,"median":-4.16145,"eighty":-2.75929,"marketCap":151994464},{"date":"2025-10-03","current":-5.907415,"twenty":-5.938047,"median":-4.221426,"eighty":-2.76177,"marketCap":157005270},{"date":"2025-10-10","current":-5.750303,"twenty":-5.938047,"median":-4.262949,"eighty":-2.769272,"marketCap":152829598},{"date":"2025-10-17","current":-5.624613,"twenty":-5.934887,"median":-4.265883,"eighty":-2.785269,"marketCap":149489061},{"date":"2025-10-24","current":-5.247544,"twenty":-5.933303,"median":-4.296782,"eighty":-2.845783,"marketCap":139467448},{"date":"2025-10-31","current":-5.436079,"twenty":-5.924891,"median":-4.3032,"eighty":-2.870708,"marketCap":144478254},{"date":"2025-11-07","current":-4.524828,"twenty":-5.916595,"median":-4.309619,"eighty":-2.884898,"marketCap":120259356},{"date":"2025-11-14","current":-4.179182,"twenty":-5.914759,"median":-4.309619,"eighty":-2.896465,"marketCap":111072877},{"date":"2025-11-21","current":-3.550733,"twenty":-5.907415,"median":-4.304871,"eighty":-2.952238,"marketCap":94370189},{"date":"2025-11-28","current":-4.304871,"twenty":-5.907415,"median":-4.296782,"eighty":-3.104751,"marketCap":114413415},{"date":"2025-12-05","current":-3.487889,"twenty":-5.875992,"median":-4.296782,"eighty":-3.112056,"marketCap":92699920},{"date":"2025-12-12","current":-3.550733,"twenty":-5.86799,"median":-4.273096,"eighty":-3.162119,"marketCap":94370189},{"date":"2025-12-19","current":-3.582156,"twenty":-5.84457,"median":-4.262949,"eighty":-3.19281,"marketCap":95205323},{"date":"2025-12-26","current":-3.92117,"twenty":-5.843755,"median":-4.262949,"eighty":-3.21786,"marketCap":97093533},{"date":"2026-01-02","current":-3.424602,"twenty":-5.82283,"median":-4.235196,"eighty":-3.269261,"marketCap":84797846},{"date":"2026-01-09","current":-3.869801,"twenty":-5.792641,"median":-4.210604,"eighty":-3.333795,"marketCap":95821565},{"date":"2026-01-16","current":-3.698571,"twenty":-5.781725,"median":-4.16249,"eighty":-3.356755,"marketCap":91581673},{"date":"2026-01-23","current":-3.835555,"twenty":-5.769156,"median":-4.143012,"eighty":-3.358933,"marketCap":94973587},{"date":"2026-01-30","current":-3.921541,"twenty":-5.737734,"median":-4.109523,"eighty":-3.368971,"marketCap":97102724},{"date":"2026-02-06","current":-3.957191,"twenty":-5.706311,"median":-4.080473,"eighty":-3.382482,"marketCap":97985476},{"date":"2026-02-13","current":-4.206744,"twenty":-5.687458,"median":-4.063335,"eighty":-3.402348,"marketCap":104164740},{"date":"2026-02-20","current":-4.519036,"twenty":-5.682154,"median":-4.084915,"eighty":-3.42469,"marketCap":106812996},{"date":"2026-02-26","current":-4.145562,"twenty":-5.66094,"median":-4.109523,"eighty":-3.425044,"marketCap":97985476}],"updateTime":1772198768894},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTOR\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1122767016","title":"Citius Oncology与Uniphar达成独家协议 将淋巴瘤药物Lymphir™分销版图扩展至欧盟","url":"https://stock-news.laohu8.com/highlight/detail?id=1122767016","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122767016?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 21:03","pubTimestamp":1770815018,"startTime":"0","endTime":"0","summary":"生物制药企业Citius Oncology宣布与欧洲领先医疗产品服务商Uniphar签署独家分销协议，正式将其创新淋巴瘤疗法Lymphir™的商业化版图拓展至欧盟市场。\n此次合作将依托Uniphar在欧洲建立的成熟分销网络，加速Lymphir™在欧盟地区的准入进程。该协议不仅强化了Citius Oncology的全球化战略布局，也为欧洲患者提供了更前沿的治疗选择。\nLymphir™作为针对特定淋巴瘤亚型的靶向疗法，此前已在部分国际市场展现出临床潜力。通过本次渠道拓展，Citius Oncology有望进一步提升其在肿瘤治疗领域的国际影响力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","BK4139","CTOR","BK4007"],"gpt_icon":0},{"id":"2606759209","title":"Citius Oncology, Inc.盘中异动 早盘股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606759209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606759209?lang=zh_cn&edition=fundamental","pubTime":"2026-01-27 22:33","pubTimestamp":1769524383,"startTime":"0","endTime":"0","summary":"北京时间2026年01月27日22时33分，Citius Oncology, Inc.股票出现异动，股价快速下挫5.42%。Citius Oncology, Inc.股票所在的制药行业中，整体涨幅为0.50%。其相关个股中，苏轩堂、Flora Growth Corp.、Apimeds Pharmaceuticals Us, Inc.涨幅较大，苏轩堂、Akanda Corp.、Flora Growth Corp.较为活跃，换手率分别为28.60%、5.54%、4.19%，振幅较大的相关个股有Flora Growth Corp.、Akanda Corp.、苏轩堂，振幅分别为17.09%、8.40%、8.39%。Citius Oncology, Inc.公司简介：Citius Oncology Inc是一家专注于开发和商业化靶向肿瘤疗法的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012722330397a3a35c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012722330397a3a35c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FLGC","BK4139","BK4183","BK4539","ZSTK","CTOR"],"gpt_icon":0},{"id":"2603769320","title":"Citius Oncology, Inc.盘中异动 大幅拉升5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603769320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603769320?lang=zh_cn&edition=fundamental","pubTime":"2026-01-13 22:42","pubTimestamp":1768315358,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日22时42分，Citius Oncology, Inc.股票出现波动，股价急速上涨5.61%。Citius Oncology, Inc.股票所在的制药行业中，整体跌幅为0.43%。其相关个股中，Im Cannabis Corp.、Biofrontera Inc.、Citius Oncology, Inc.涨幅较大，Akanda Corp.、Gelteq Limited、苏轩堂较为活跃，换手率分别为14.79%、5.41%、4.31%，振幅较大的相关个股有脑再生科技、大自然药业、Biofrontera Inc.，振幅分别为16.55%、11.06%、10.04%。Citius Oncology, Inc.公司简介：Citius Oncology Inc是一家专注于开发和商业化靶向肿瘤疗法的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011322423897a1a7b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011322423897a1a7b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTOR"],"gpt_icon":0},{"id":"2601842432","title":"Citius Oncology, Inc.盘中异动 早盘急速下挫6.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601842432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601842432?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 22:32","pubTimestamp":1767709948,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日22时32分，Citius Oncology, Inc.股票出现异动，股价急速跳水6.96%。Citius Oncology, Inc.股票所在的制药行业中，整体涨幅为0.33%。其相关个股中，Caring Brands, Inc.、Gelteq Limited、脑再生科技涨幅较大，Akanda Corp.、Redhill Biopharma Ltd、Cbdmd, Inc.较为活跃，换手率分别为14.13%、3.33%、0.81%，振幅较大的相关个股有Caring Brands, Inc.、脑再生科技、Akanda Corp.，振幅分别为8.86%、6.33%、5.22%。Citius Oncology, Inc.公司简介：Citius Oncology Inc是一家专注于开发和商业化靶向肿瘤疗法的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106223228953c16f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106223228953c16f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTOR"],"gpt_icon":0},{"id":"2595500753","title":"Citius Oncology, Inc.盘中异动 早盘大幅下挫5.31%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595500753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595500753?lang=zh_cn&edition=fundamental","pubTime":"2025-12-29 22:48","pubTimestamp":1767019725,"startTime":"0","endTime":"0","summary":"北京时间2025年12月29日22时48分，Citius Oncology, Inc.股票出现波动，股价大幅跳水5.31%。Citius Oncology, Inc.股票所在的制药行业中，整体涨幅为0.09%。其相关个股中，Caring Brands, Inc.、Akanda Corp.、脑再生科技涨幅较大，Akanda Corp.、大自然药业、Cbdmd, Inc.较为活跃，换手率分别为117.47%、6.59%、5.20%，振幅较大的相关个股有Caring Brands, Inc.、脑再生科技、Cbdmd, Inc.，振幅分别为31.25%、18.85%、11.78%。Citius Oncology, Inc.公司简介：Citius Oncology Inc 是一家专业制药公司，致力于开发和商业化针对未满足需求的重症监护产品，专注于肿瘤产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229224845a4868ab8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229224845a4868ab8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTOR","CABR","BK4183"],"gpt_icon":0},{"id":"1194721703","title":"Citius Oncology完成1800万美元的同时注册直接发行和私募配售，价格符合纳斯达克规则","url":"https://stock-news.laohu8.com/highlight/detail?id=1194721703","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194721703?lang=zh_cn&edition=fundamental","pubTime":"2025-12-11 05:31","pubTimestamp":1765402278,"startTime":"0","endTime":"0","summary":"Citius Oncology完成1800万美元的同时注册直接发行和私募配售，价格符合纳斯达克规则","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"1186772713","title":"Citius Oncology Inc - 直接发行以每股1.09美元购买1,284,404股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1186772713","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186772713?lang=zh_cn&edition=fundamental","pubTime":"2025-12-09 21:33","pubTimestamp":1765287209,"startTime":"0","endTime":"0","summary":"Citius Oncology Inc - 直接发行以每股1.09美元购买1,284,404股普通股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CTOR","BK4007","CTXR"],"gpt_icon":0},{"id":"1111513577","title":"Citius Oncology 宣布以市场定价进行1800万美元的注册直销及私人投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1111513577","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111513577?lang=zh_cn&edition=fundamental","pubTime":"2025-12-09 21:31","pubTimestamp":1765287103,"startTime":"0","endTime":"0","summary":"Citius Oncology 宣布以市场定价进行1800万美元的注册直销及私人投资","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","BK4139","CTOR","BK4007"],"gpt_icon":0},{"id":"1178681935","title":"Citius Oncology通过与Er-Kim的独家协议扩展Lymphir™在土耳其和中东国家的分销","url":"https://stock-news.laohu8.com/highlight/detail?id=1178681935","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178681935?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 21:37","pubTimestamp":1764855430,"startTime":"0","endTime":"0","summary":"Citius Oncology通过与Er-Kim的独家协议扩展Lymphir™在土耳其和中东国家的分销","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","CTOR","CTXR"],"gpt_icon":0},{"id":"1108685707","title":"Citius Oncology 宣布 Lymphir™ 上市，作为切肤性 T 细胞淋巴瘤的新型癌症免疫疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1108685707","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108685707?lang=zh_cn&edition=fundamental","pubTime":"2025-12-02 01:01","pubTimestamp":1764608490,"startTime":"0","endTime":"0","summary":"Citius Oncology 宣布在美国商业化推出 Lymphir™，这是一种针对切肤性 T 细胞淋巴瘤的新型癌症免疫疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","BK4139","CTOR","BK4007"],"gpt_icon":0},{"id":"2585127830","title":"Citius Oncology, Inc.盘中异动 急速上涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585127830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585127830?lang=zh_cn&edition=fundamental","pubTime":"2025-11-21 22:30","pubTimestamp":1763735424,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日22时30分，Citius Oncology, Inc.股票出现波动，股价急速上涨5.62%。Citius Oncology, Inc.股票所在的制药行业中，整体涨幅为0.00%。其相关个股中，Shuttle Pharmaceuticals Holdings, Inc.、Scilex Holding Company C/Wts 10/11/2027 、Citius Oncology, Inc.涨幅较大，Shuttle Pharmaceuticals Holdings, Inc.、Inmed Pharmaceuticals Inc.、Citius Oncology, Inc.较为活跃，换手率分别为170.12%、3.94%、1.49%，振幅较大的相关个股有Citius Oncology, Inc.、Scynexis, Inc.、Inmed Pharmaceuticals Inc.，振幅分别为4.42%、2.49%、2.36%。Citius Oncology, Inc.公司简介：Citius Oncology Inc 是一家专业制药公司，致力于开发和商业化针对未满足需求的重症监护产品，专注于肿瘤产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511212230259777da73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511212230259777da73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTOR"],"gpt_icon":0},{"id":"1149323781","title":"Citius Oncology与麦克森签署美国分销协议以支持Lymphir™商业推广","url":"https://stock-news.laohu8.com/highlight/detail?id=1149323781","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149323781?lang=zh_cn&edition=fundamental","pubTime":"2025-10-20 20:37","pubTimestamp":1760963831,"startTime":"0","endTime":"0","summary":"Citius Oncology与麦克森签署美国分销协议以支持Lymphir™商业推广","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1934455863.HKD","LU0965508806.USD","LU0251142724.SGD","MCK","LU2468319806.SGD","LU0742534661.SGD","LU0868494617.USD","LU1037948541.HKD","LU0048573561.USD","LU0868494708.USD","LU0965509010.AUD","LU0965509283.SGD","LU1934455194.USD","BK4585","LU0965509101.SGD","LU1934455277.USD","LU1585245621.USD","LU1814569148.SGD","LU1057294990.SGD","LU1506573853.SGD","LU1061106388.HKD","BK4175","LU0203347892.USD","LU1430594728.SGD","LU1023059063.AUD","LU2089984988.USD","LU1983260115.SGD","LU0314106906.USD","CTXR","BK4139","BK4533","LU1037948897.HKD","LU0203345920.USD","LU1366192091.USD","CTOR","LU0122379950.USD","LU0942090050.USD","LU2112291526.USD","LU0861579265.USD","BK4588","LU2324357040.USD","LU0251131958.USD","LU0432979614.USD"],"gpt_icon":0},{"id":"1125386068","title":"Citius Oncology与Eversana签订独家商业化协议，助力计划于2025年第四季度推出Lymphir™","url":"https://stock-news.laohu8.com/highlight/detail?id=1125386068","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125386068?lang=zh_cn&edition=fundamental","pubTime":"2025-10-16 20:48","pubTimestamp":1760618892,"startTime":"0","endTime":"0","summary":"Citius Oncology与Eversana签订独家商业化协议，助力计划于2025年第四季度推出Lymphir™","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTXR","BK4139","CTOR"],"gpt_icon":0},{"id":"1198374736","title":"Citius Oncology宣布完成900万美元注册直接发行和同步私募配售定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1198374736","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198374736?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 20:31","pubTimestamp":1757421080,"startTime":"0","endTime":"0","summary":"Citius Oncology宣布完成总额900万美元的注册直接发行和同步私募配售的定价工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","CTXR","BK4139","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}]}}